[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:proteinuria":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":55,"states":56},"Proteinuria",7,6,[8,16,23,29,36,42,48],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07224776","Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria",[12],"Phase 1","RECRUITING","2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.222040Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05196035","A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria",[20],"Phase 3","2026-08-03T02:12:47.795874Z","2026-05-05T02:43:28.356962Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05457283","A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria",[20],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:28.123029Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06013865","Empagliflozin Treatment in Kidney Transplant Recipients",[33],"Phase 4","2026-08-26T02:18:46.137046Z","2026-05-05T02:43:29.671117Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT01094327","Proteinuria in Pre and Post Transplant",[],"2026-08-26T02:17:40.683658Z","2026-05-13T02:55:06.066948Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT01016613","Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center",[],"2026-08-26T02:15:59.318403Z","2026-05-13T02:55:06.066199Z",{"nct_id":49,"title":50,"phases":51,"status":52,"updated_at":53,"content_modified":54},"NCT07431931","Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria",[],"NOT_YET_RECRUITING","2026-08-26T02:17:17.791881Z","2026-05-05T02:43:27.135242Z",[],[57,61,65],{"state":58,"count":59,"slug":60},"Pennsylvania",5,"pennsylvania",{"state":62,"count":63,"slug":64},"Florida",3,"florida",{"state":66,"count":63,"slug":67},"Iowa","iowa"]